Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 44 results
Author
Title
Type
Year
Filters:
Author
is
Demichelis, Francesca
[Clear All Filters]
2011
Berger MF
,
Lawrence MS
,
Demichelis F
,
Drier Y
,
Cibulskis K
,
Sivachenko AY
,
Sboner A
,
Esgueva R
,
Pflueger D
,
Sougnez C
et al.
. 2011.
The genomic complexity of primary human prostate cancer.
.
Nature. 470(7333):214-20.
Beltran H
,
Rickman DS
,
Park K
,
Chae SSuk
,
Sboner A
,
MacDonald TY
,
Wang Y
,
Sheikh KL
,
Terry S
,
Tagawa ST
et al.
. 2011.
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
.
Cancer Discov. 1(6):487-95.
Svensson MA
,
Lafargue CJ
,
MacDonald TY
,
Pflueger D
,
Kitabayashi N
,
Santa-Cruz AM
,
Garsha KE
,
Sathyanarayana UG
,
Riley JP
,
Yun CS
et al.
. 2011.
Testing mutual exclusivity of ETS rearranged prostate cancer.
.
Lab Invest. 91(3):404-12.
2012
Barbieri CE
,
Baca SC
,
Lawrence MS
,
Demichelis F
,
Blattner M
,
Theurillat J-P
,
White TA
,
Stojanov P
,
Van Allen E
,
Stransky N
et al.
. 2012.
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
.
Nat Genet. 44(6):685-9.
Demichelis F
,
Setlur SR
,
Banerjee S
,
Chakravarty D
,
Chen JYun Helen
,
Chen CX
,
Huang J
,
Beltran H
,
Oldridge DA
,
Kitabayashi N
et al.
. 2012.
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
.
Proc Natl Acad Sci U S A. 109(17):6686-91.
Rickman DS
,
T Soong D
,
Moss B
,
Mosquera JMiguel
,
Dlabal J
,
Terry S
,
MacDonald TY
,
Tripodi J
,
Bunting K
,
Najfeld V
et al.
. 2012.
Oncogene-mediated alterations in chromatin conformation.
.
Proc Natl Acad Sci U S A. 109(23):9083-8.
2013
Lin P-C
,
Chiu Y-L
,
Banerjee S
,
Park K
,
Mosquera JMiguel
,
Giannopoulou E
,
Alves P
,
Tewari AK
,
Gerstein MB
,
Beltran H
et al.
. 2013.
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression.
.
Cancer Res. 73(3):1232-44.
Demichelis F
,
Garraway LA
,
Rubin MA
. 2013.
Molecular archeology: unearthing androgen-induced structural rearrangements in prostate cancer genomes.
.
Cancer Cell. 23(2):133-5.
Baca SC
,
Prandi D
,
Lawrence MS
,
Mosquera JMiguel
,
Romanel A
,
Drier Y
,
Park K
,
Kitabayashi N
,
MacDonald TY
,
Ghandi M
et al.
. 2013.
Punctuated evolution of prostate cancer genomes.
.
Cell. 153(3):666-77.
2015
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
Boysen G
,
Barbieri CE
,
Prandi D
,
Blattner M
,
Chae S-S
,
Dahija A
,
Nataraj S
,
Huang D
,
Marotz C
,
Xu L
et al.
. 2015.
SPOP mutation leads to genomic instability in prostate cancer.
.
Elife. 4
Beltran H
,
Eng K
,
Mosquera JMiguel
,
Sigaras A
,
Romanel A
,
Rennert H
,
Kossai M
,
Pauli C
,
Faltas B
,
Fontugne J
et al.
. 2015.
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
.
JAMA Oncol. 1(4):466-74.
2016
Faltas BM
,
Prandi D
,
Tagawa ST
,
Molina AM
,
Nanus DM
,
Sternberg C
,
rosenberg jonathan
,
Mosquera JMiguel
,
Robinson B
,
Elemento O
et al.
. 2016.
Clonal evolution of chemotherapy-resistant urothelial carcinoma.
.
Nat Genet. 48(12):1490-1499.
Beltran H
,
Prandi D
,
Mosquera JMiguel
,
Benelli M
,
Puca L
,
Cyrta J
,
Marotz C
,
Giannopoulou E
,
Chakravarthi BVSK
,
Varambally S
et al.
. 2016.
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
.
Nat Med. 22(3):298-305.
Rubin MA
,
Girelli G
,
Demichelis F
. 2016.
Genomic Correlates to the Newly Proposed Grading Prognostic Groups for Prostate Cancer.
.
Eur Urol. 69(4):557-60.
Dardenne E
,
Beltran H
,
Benelli M
,
Gayvert K
,
Berger A
,
Puca L
,
Cyrta J
,
Sboner A
,
Noorzad Z
,
MacDonald T
et al.
. 2016.
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.
.
Cancer Cell. 30(4):563-577.
Khurana E
,
Fu Y
,
Chakravarty D
,
Demichelis F
,
Rubin MA
,
Gerstein M
. 2016.
Role of non-coding sequence variants in cancer.
.
Nat Rev Genet. 17(2):93-108.
2017
Pauli C
,
Hopkins BD
,
Prandi D
,
Shaw R
,
Fedrizzi T
,
Sboner A
,
Sailer V
,
Augello M
,
Puca L
,
Rosati R
et al.
. 2017.
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
.
Cancer Discov.
Mu P
,
Zhang Z
,
Benelli M
,
Karthaus WR
,
Hoover E
,
Chen C-C
,
Wongvipat J
,
Ku S-Y
,
Gao D
,
Cao Z
et al.
. 2017.
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
.
Science. 355(6320):84-88.
« first
‹ previous
1
2
(current)